|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
993263 |
| 003 |
ICU |
| 005 |
20231221203102.8 |
| 008 |
891012s1989 nyua b 101 0 eng c |
| 010 |
|
|
|a 89012128 //r90
|
| 020 |
|
|
|a 0845126997
|
| 035 |
|
|
|a (ICU)BID12283135
|
| 035 |
|
|
|a (OCoLC)19774576
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
0 |
|a RC271.B53
|b M43 1989
|
| 060 |
|
|
|a W3 U17n new ser. v. 100
|a WD 308 M486 1988
|
| 082 |
0 |
0 |
|a 616.99/4061
|2 20
|
| 245 |
0 |
0 |
|a Mechanisms of action and therapeutic applications of biologicals in cancer and immune deficiency disorders :
|b proceedings of a Hoffmann-La Roche-Smith Kline & French-UCLA symposium, held at Keystone, Colorado, April 23-30, 1988 /
|c editors, Jerome E. Groopman, David W. Golde, Charles H. Evans.
|
| 260 |
0 |
|
|a New York :
|b Liss,
|c c1989.
|
| 300 |
|
|
|a xix, 406 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a UCLA symposia on molecular and cellular biology
|v new ser., v. 100
|
| 504 |
|
|
|a Includes bibliographies and index.
|
| 650 |
|
0 |
|a Biological response modifiers
|x Congresses.
|
| 650 |
|
0 |
|a Monoclonal antibodies
|x Therapeutic use
|x Congresses.
|
| 650 |
|
0 |
|a Cancer
|x Immunotherapy
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2009118244
|
| 650 |
|
0 |
|a AIDS (Disease)
|x Immunotherapy
|x Congresses.
|
| 650 |
|
2 |
|a Acquired Immunodeficiency Syndrome
|x drug therapy
|x congresses.
|
| 650 |
|
2 |
|a Antibodies, Monoclonal
|x therapeutic use
|x congresses.
|
| 650 |
|
2 |
|a Colony-Stimulating Factors
|x therapeutic use
|x congresses.
|
| 650 |
|
2 |
|a Hematopoietic Stem Cells
|x congresses.
|
| 650 |
|
2 |
|a Interleukins
|x therapeutic use
|x congresses.
|
| 650 |
|
7 |
|a Biological response modifiers.
|2 fast
|0 http://id.worldcat.org/fast/fst00832312
|
| 650 |
|
7 |
|a Cancer
|x Immunotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845386
|
| 650 |
|
7 |
|a Monoclonal antibodies
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst01025554
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
0 |
|a Groopman, Jerome E.
|0 http://id.loc.gov/authorities/names/n84045073
|1 http://viaf.org/viaf/3327191
|
| 700 |
1 |
0 |
|a Golde, David W.
|0 http://id.loc.gov/authorities/names/n78059965
|1 http://viaf.org/viaf/55406621
|
| 700 |
1 |
0 |
|a Evans, Charles H.
|q (Charles Hawes),
|d 1940-
|0 http://id.loc.gov/authorities/names/n88185237
|1 http://viaf.org/viaf/77875461
|
| 710 |
2 |
0 |
|a Hoffmann-La Roche, inc.
|1 http://viaf.org/viaf/122614564
|
| 710 |
2 |
0 |
|a Smith, Kline & French Laboratories.
|
| 710 |
2 |
0 |
|a University of California, Los Angeles
|0 http://id.loc.gov/authorities/names/n79046090
|1 http://viaf.org/viaf/122477083
|
| 903 |
|
|
|a xHeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i ff43f3e9-2f18-5c13-8a96-2e78d564dedf
|s b6b29de1-b204-5de2-b61c-38d710f6ac22
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.B53M430 1989
|l ASR
|c ASR-SciASR
|i 1843968
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.B53M430 1989
|l ASR
|c ASR-SciASR
|e CRERAR
|b 29840199
|i 2224929
|
